Shafiqur Rahman, Sumbal Bibi, Tariq Javed, Fiaz Alam, Atif Ali, Ziaur Rehman Qureshi, Sayyad Ali, Majeed Ullah, Hassan Bin Asad, Rid Hasan S M Farid, Jean Marc Sabatier, Albert A Rizvanov.
Review: Therapeutic potential of carbonic anhydrase inhibitors..
Pak J Pharm Sci Jan ;32(2):709-20.

Enzymes are biological catalyst involve in different biochemical reactions. But over activation of these biomolecules can cause disease thus different inhibitors and knockout therapies are use in current clinical practice. Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are involved in numerous physiological and pathological processes, including gluconeogenesis, lipogenesis, ureagenesis, tumorigenicity and the growth and virulence of various pathogens. In addition to the established role of CA inhibitors (CAIs) as diuretics and antiglaucoma drugs, it has recently emerged that CAIs could have potential as novel anti-obesity, anticancer and anti-infective drugs. Furthermore, recent studies suggest that CA activation may provide a novel therapy for Alzheimer's disease. This article discusses the biological rationale for the novel uses of inhibitors or activators of CA activity in multiple diseases, and highlights progress in the development of specific modulators of the relevant CA isoforms, some of which are now being evaluated in clinical trials.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com